Clinical Trials · NCT00565097
Lanreotide as Treatment of Polycystic Livers
- Phase
- Phase 2/Phase 3
- Recruitment status
- Completed
- Sponsor
- Radboud University Medical Center
- Enrollment
- 38
- Start date
- Oct 2007
- Locations
- 2 sites, Belgium, Netherlands
- Primary endpoint
- Reduction of total liver volume as determined by CT scan